-- XENITH-UC, a Phase 2b study of XmAb942 in participants with ulcerative colitis, to begin in the second half of 2025 -- -- Single and multiple doses of XmAb942 are well tolerated and safety profile ...

Pictured: A 3D structure of an organoid formed from human bowel cancer cells. Blue marks the nucleus of the individual cell, green is a protein that sticks each cell together and red shows the cancer ...